Analyst Ratings For Ionis Pharmaceuticals (NASDAQ:IONS)
Today, Sanford C. Bernstein reiterated its Market Perform rating on Ionis Pharmaceuticals (NASDAQ:IONS) with a price target of $55.00.
Some recent analyst ratings include
- 2/20/2018-Sanford C. Bernstein Reiterated Rating of Market Perform.
- 10/17/2017-Needham & Company LLC Reiterated Rating of Buy.
- 10/13/2017-Stifel Nicolaus Reiterated Rating of Hold.
- 10/6/2017-Goldman Sachs Group Reiterated Rating of Sell .
Recent Insider Trading Activity For Ionis Pharmaceuticals (NASDAQ:IONS)
Ionis Pharmaceuticals (NASDAQ:IONS) has insider ownership of 2.13% and institutional ownership of 91.01%.
- On 2/15/2018 Joseph Klein III, Director, sold 3,000 with an average share price of $48.99 per share and the total transaction amounting to $146,970.00.
- On 2/1/2018 C Frank Bennett, SVP, sold 12,500 with an average share price of $52.50 per share and the total transaction amounting to $656,250.00.
- On 1/30/2018 Joseph Klein III, Director, sold 3,000 with an average share price of $52.86 per share and the total transaction amounting to $158,580.00.
- On 1/29/2018 Patrick R O’neil, SVP, sold 355 with an average share price of $55.00 per share and the total transaction amounting to $19,525.00.
- On 1/29/2018 Stanley T Crooke, Chairman, sold 11,000 with an average share price of $54.12 per share and the total transaction amounting to $595,320.00.
- On 1/25/2018 Patrick R O’neil, SVP, sold 645 with an average share price of $55.00 per share and the total transaction amounting to $35,475.00.
- On 1/16/2018 B Lynne Parshall, Director, sold 5,986 with an average share price of $51.76 per share and the total transaction amounting to $309,835.36.
Recent Trading Activity for Ionis Pharmaceuticals (NASDAQ:IONS)
Shares of Ionis Pharmaceuticals closed the previous trading session at 49.53 down -0.52 1.04% with shares trading hands.